TEVA PHARMACEUTICAL INDUSTRIES LIMITED Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for the quarter ending 2016-12-31 was 0.00 shares.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for the quarter ending 2016-09-30 was 0.00 shares.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for the quarter ending 2016-06-30 was 0.00 shares.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for the quarter ending 2016-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for fiscal 2017 was 0.00 shares.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for fiscal 2016 was 0.00 shares, a 100.00% decline from fiscal 2015.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED treasury stock, shares, acquired for fiscal 2015 was 7.70M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2017-12-31 | 0.00 shares 10-K · filed 2018-02-12 | |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | 0.00 shares 10-K · filed 2018-02-12 |
| 2016-09-30 | 0.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2016-11-15 | 0.00 shares derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-06-30 | 0.00 shares derived: 6-K 6 month − 6-K 3 month · filed 2016-08-04 | 0.00 shares derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-03-31 | 0.00 shares 6-K · filed 2016-05-09 | 0.00 shares derived: sum of 4 quarters · filed 2018-02-12 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | 7.70M shares 10-K · filed 2018-02-12 |
| 2015-09-30 | 0.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2016-11-15 | 16.40M shares derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | 0.00 shares derived: 6-K 6 month − 6-K 3 month · filed 2016-08-04 | 16.40M shares derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | 7.70M shares 6-K · filed 2016-05-09 | 16.40M shares derived: sum of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | 8.70M shares derived: 20-F 12 month − 6-K 9 month · filed 2017-02-15 | 8.70M shares 20-F · filed 2017-02-15 |
| 2014-09-30 | 0.00 shares 6-K · filed 2014-10-30 | 0.00 shares derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | 0.00 shares 6-K · filed 2014-07-31 | 0.00 shares derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-03-31 | 0.00 shares 6-K · filed 2015-04-30 | 7.60M shares derived: sum of 4 quarters · filed 2016-02-11 |
| 2013-12-31 | 0.00 shares derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | 12.80M shares 20-F · filed 2016-02-11 |
| 2013-09-30 | 0.00 shares 6-K · filed 2014-10-30 | 25.50M shares derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-06-30 | 7.60M shares 6-K · filed 2014-07-31 | 25.50M shares derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-04-01 | 5.20M shares 6-K · filed 2014-05-02 | 21.40M shares derived: sum of 4 quarters · filed 2015-02-09 |
| 2012-12-31 | 12.70M shares derived: 20-F 12 month − 6-K 9 month · filed 2015-02-09 | 28.10M shares 20-F · filed 2015-02-09 |
| 2012-09-30 | 0.00 shares 6-K · filed 2013-10-31 | 10.60M shares derived: sum of 4 quarters · filed 2014-02-10 |
| 2012-06-30 | 3.50M shares 6-K · filed 2012-08-02 | 16.70M shares derived: sum of 4 quarters · filed 2014-02-10 |
| 2012-03-31 | 3.50M shares 6-K · filed 2013-08-01 | 15.20M shares derived: sum of 4 quarters · filed 2014-02-10 |
| 2011-12-31 | 3.60M shares derived: 20-F 12 month − 6-K 9 month · filed 2014-02-10 | 19.60M shares 20-F · filed 2014-02-10 |
| 2011-09-30 | 6.10M shares 6-K · filed 2012-11-01 | |
| 2011-06-30 | 2.00M shares 6-K · filed 2012-08-02 | |
| 2011-03-31 | 7.90M shares 6-K · filed 2011-05-11 | |
| 2010-12-31 | 1.90M shares 20-F · filed 2013-02-12 |